Pharmacokinetics in the Critically Ill
1200 j lipman
Seasonal influenza - current perspective with special reference to India - aug 2011
VRE - treatment options for severe infections Dr Nick Brown Addenbrookes Hospital, Cambridge 14 March 2013 Conflict of interest: None.
1 Optimal Prophylaxis: Case for Fluconazole/ Itraconazole Pranatharthi H. Chandrasekar, MD Wayne State University School of Medicine Karmanos Cancer Institute.
Cardiovascular Side Effects of HIV Treatment Jean-Guy Baril, MD Mark Wainberg, Phd.
Preparing for Direct Acting Antivirals (DAAs) in PracticeNew Paradigms in the Management of HCV Sherilyn C. Brinkley, MSN, CRNP Nurse Practitioner/Program.
New Paradigms in the management of HIV/HCV co- infected patients Sanjay Bhagani Royal Free Hospital London.
Colonization and Decolonization of MRSA Ed Septimus, MD, FIDSA, SHEA, FACP [email protected].
Latest Developments in the Treatment of Invasive Aspergillosis William J. Steinbach, MD Assistant Professor of Pediatrics, Molecular Genetics, and Microbiology.
Neurological toxicity of Tri-azole Antifungals DR CAROLINE BAXTER Clinical Research Fellow .
Clinical failure and its management David W. Denning Director, National Aspergillosis Centre University Hospital South Manchester [Wythenshawe Hospital]
![Clinical failure and its management David W. Denning Director, National Aspergillosis Centre University Hospital South Manchester [Wythenshawe Hospital]](https://static.fdocuments.us/doc/330x215/551796265503463e368b57c0/clinical-failure-and-its-management-david-w-denning-director-national-aspergillosis-centre-university-hospital-south-manchester-wythenshawe-hospital.jpg)
